Navigation Links
$450,000 Awarded for Innovative Asthma Research Into Death by Drowning in Mucus
Date:9/22/2009

SAN FRANCISCO, Sept. 22 /PRNewswire/ -- Dr. Daniel L Minor, a specialist in molecular pharmacology, has been awarded $450,000 by the American Asthma Foundation (AAF). Dr. Minor will turn his expertise to controlling the greatest danger in asthma--the production of lung fluids (mucus) in amounts that flood the airways, causing death by drowning.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090922/SF75312-b)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090818/SF62537LOGO-a)

Dr. Minor's research into asthma will:

  • define the process that regulates the level of calcium in the airway cells that produce mucus,
  • develop new drugs that block excess production of mucus fluids, thereby opening the airways and preventing death.

Dr. Minor is Associate Professor of Biochemistry and Biophysics and of Cellular and Molecular Pharmacology at the University of California San Francisco. He is recognized as a leading expert on cell membrane activity.

"These cutting-edge, high risk and potentially breakthrough research projects, like Dr. Minor's, are at the heart of the American Asthma Foundation's approach to funding innovative approaches essential to ending the asthma epidemic," commented Marion O. Sandler, Chairman of the Board. Continuing on, Sandler said, "The American Asthma Foundation awards have produced 17 potential breakthroughs, in less than 10 years, with 11 of these taken up by pharmaceutical companies. After five decades with virtually no improvements, this large number of discoveries in such a brief period of time documents the success of our programs."

Over 23 million, or one in 13 people, in the United States have asthma. More Americans have asthma than coronary heart disease, cancer or Parkinson's disease. Asthma is the most serious chronic disease of childhood and disproportionately strikes the poor.

A brief description of Dr. Minor's project can be seen at www.americanasthmafoundation.org/research-program/2009-research-grant-awardees.

TO ARRANGE AN INTERVIEW WITH AN AAF EXECUTIVE OR RESEARCHER, OR FOR FURTHER INFORMATION, CONTACT:

Seth D. Feldman, Deputy Executive Director, American Asthma Foundation

415-404-3484, sfeldman@americanasthma.org

www.americanasthmafoundation.org


'/>"/>
SOURCE American Asthma Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives
2. $450,000 sweetener in colon cancer battle
3. BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza
4. Medical Device Manufacturer MRPC Awarded ISO 13485 Certification
5. Prime Staffing Awarded Certification from The Joint Commission
6. HMS Awarded Third Party Liability Services Contract by Minnesota
7. Dr. Dorin Panescu, NewCardios Chief Technology Officer, Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology Society
8. FaxBack Awarded "Best of Show" at ITEXPO West 2009
9. High Point Solutions has Been Awarded the Prestigious Gold Certification from Cisco Systems
10. Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology
11. CI Faculty Member Awarded Nearly $1 Million NSF Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Hackensack, N.J. (PRWEB) , ... April 26, 2017 ... ... fluency, Inc. in Hackensack, N.J. has been honored by Enterprising Women magazine ... program that recognizes the world’s top women business owners. Winners have demonstrated that ...
(Date:4/26/2017)... ... 2017 , ... RawTrition now brings you BioEnergy which is a powder capsule ... , RawTrition is taking nutrients to the next level! The superfoods in ... raw form (unlike the synthetically made options that are on the market). , Founder ...
(Date:4/26/2017)... FL (PRWEB) , ... April 26, 2017 , ... ... and human performance, is proud to announce that it has received 510(k) clearance ... technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
(Date:4/25/2017)... ... 2017 , ... The doctors at Wall Centre Dental are now expanding their ... require sedation to receive dental care. The doctors offer three treatment options to put ... to oral surgery, at their dental office in Vancouver. Wall Centre Dental is currently ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... YORK , April 19, 2017 The Mobile ... to showcase a healthy CAGR during the forecast period ... type in the global digital mobile X-Ray devices market, which ... Mn in 2017, expanding at a CAGR of 7% over ... absolute $ opportunity of more than US$ 100 Mn in ...
Breaking Medicine Technology: